Atopic dermatitis market tipped to hit $22 billion by 2033

The atopic dermatitis market across the seven major markets is forecast to nearly triple in value over the next decade, driven by advances in targeted therapies and a deeper understanding of disease mechanisms.

According to a new analysis by GlobalData, the market in the USA, France, Germany, Italy, Spain, the UK and Japan is expected to grow from $8.5 billion in 2023 to $22.4 billion by 2033. This rise, underpinned by a projected 10.2% annual growth rate, reflects a surge in treatment options and a growing drug-treated population expected to exceed 25 million.

GlobalData’s Filippos Maniatis said the field had “an impressive pipeline of new products,” noting the shift away from older, broad-acting immunomodulatory drugs to more targeted therapies. This pivot has been catalyzed by the approval of several systemic agents and a clearer picture of the disease’s underlying biology.